Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01963481
Title Exemestane and Cyclophosphamide for Metastatic Breast Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors New York University School of Medicine
Indications

Her2-receptor negative breast cancer

Therapies

Cyclophosphamide

Exemestane

Age Groups: adult
Covered Countries USA


No variant requirements are available.